Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm, Open-label Study to Explore the Salivary Concentration of Cetylpyridinium Chloride Buccal Tablets After Single-dose Administration in Healthy Subjects

NCT05802628 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT05802628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05802628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm, Open-label Study to Explore the Salivary Concentration of Cetylpyridinium Chloride Buccal Tablets After Single-dose Administration in Healthy Subjects
Lead sponsor
Peking University People's Hospital
Phase
Phase 4
Overall status
Completed
Start date
April 10, 2023
Completion date
April 18, 2023
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gingivitis, pharyngitis acute